Abliva AB (publ) (STO: ABLI)
Sweden
· Delayed Price · Currency is SEK 0.420
-0.001 (-0.24%)
Dec 20, 2024, 5:29 PM CET
Abliva AB Revenue
Abliva AB had revenue of 137.00K SEK in the twelve months ending September 30, 2024. In the year 2023, Abliva AB had annual revenue of 137.00K with 341.94% growth.
Revenue
137.00K
Revenue Growth
+341.94%
P/S Ratio
n/a
Revenue / Employee
22.83K
Employees
8
Market Cap
676.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 137.00K | 106.00K | 341.94% |
| Dec 31, 2022 | 31.00K | -120.00K | -79.47% |
| Dec 31, 2021 | 151.00K | -1.57M | -91.20% |
| Dec 31, 2020 | 1.72M | -1.92M | -52.78% |
| Dec 31, 2019 | 3.63M | 1.17M | 47.36% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Vitrolife AB (publ) | 3.56B |
| Bonesupport Holding AB (publ) | 814.46M |